Protein protects against non-alcoholic fatty liver disease

Researchers propose a possible therapeutic target to treat fatty liver, a disease for which there is currently no treatment. Non-alcoholic fatty liver disease describes several liver dysfunctions of varying severity, characterised by the accumulation of fat in hepatic cells and not caused by high alcohol consumption. This disease, one of the most common in developed countries, affects around 25% of the population worldwide. A team at the Institute for Research in Biomedicine (IRB Barcelona) has identified one of the factors that confer protection against this condition, namely the protein Mitofusin 2.

“Mitofusin 2 emerges as a possible therapeutic target to tackle fatty liver, a disease for which no treatments are available. Early diagnosis of this disease is difficult and physicians are currently only recommending weight loss to alleviate the condition,” explains Antonio Zorzano, head of the Complex Metabolic Diseases and Mitochondria laboratory at IRB Barcelona.

One of the most serious forms of fatty acid is non-alcoholic steatohepatitis (NASH), in which the accumulation of fat is accompanied by inflammation. In this study published in the journal Cell, the researchers have observed a decrease in the levels of Mitofusin 2 in patients with NASH, even in early stages of the disease.

Like humans, mice also develop this disease when the levels of Mitofusin 2 decreases. By injecting a mouse model of NASH with an adenovirus enconding Mitofusin 2 protein — a virus modified to artificially express proteins — the team headed by Zorzano, senior professor at the University of Barcelona and researcher of the CIBERDEM Programme, has observed the amelioration of NASH.

“We are now studying different approaches that will allow us to enhance the levels of Mitofusin 2, without producing side effects, and that could be relevant in the treatment of non-alcoholic fatty liver disease,” says María Isabel Hernández-Alvarez, postdoctoral fellow at IRB Barcelona and first author of the study.

This work has been supported by funding from the Ministry of Science, Innovation and Universities (previously known as MINECO), the Catalan Government, the Instituto de Salud Carlos III, CIBERDEM, “la Caixa” Foundation and the Pere Virgili Institute (IISPV).

Story Source:

Materials provided by Institute for Research in Biomedicine (IRB Barcelona). Note: Content may be edited for style and length.

Share Button

New approach for solving protein structures from tiny crystals

Using x-rays to reveal the atomic-scale 3-D structures of proteins has led to countless advances in understanding how these molecules work in bacteria, viruses, plants, and humans — and has guided the development of precision drugs to combat diseases such as cancer and AIDS. But many proteins can’t be grown into crystals large enough for their atomic arrangements to be deciphered. To tackle this challenge, scientists at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory and colleagues at Columbia University have developed a new approach for solving protein structures from tiny crystals.

The method relies on unique sample-handling, signal-extraction, and data-assembly approaches, and a beamline capable of focusing intense x-rays at Brookhaven’s National Synchrotron Light Source II (NSLS-II) — a DOE Office of Science user facility — to a millionth-of-a-meter spot, about one-fiftieth the width of a human hair.

“Our technique really opens the door to dealing with microcrystals that have been previously inaccessible, including difficult-to-crystallize cell-surface receptors and other membrane proteins, flexible proteins, and many complex human proteins,” said Brookhaven Lab scientist Qun Liu, the corresponding author on the study, which was published on May 3, 2019, in IUCrJ, a journal of the International Union of Crystallography.

Deciphering protein structures

Protein crystallography has been a dominant method for solving protein structures since 1958, improving over time as x-ray sources have grown more powerful, allowing more precise structure determinations. To determine a protein structure, scientists measure how x-rays like those generated at NSLS-II diffract, or bounce off, the atoms in an ordered crystalline lattice consisting of many copies of the same protein molecule all arrayed the same way. The diffraction pattern conveys information about where the atoms are located. But it’s not sufficient.

“Only the amplitudes of diffracted x-ray ‘waves’ are recorded on the detector, but not their phases (the timing between waves),” said Liu. “Both are required to reconstruct a 3-D structure. This is the so-called crystallographic phase problem.”

Crystallographers have solved this problem by collecting phase data from a different kind of scattering, known as anomalous scattering. Anomalous scattering occurs when atoms heavier than a protein’s main components of carbon, hydrogen, and nitrogen absorb and re-emit some of the x-rays. This happens when the x-ray energy is close to the energy those heavy atoms like to absorb. Scientists sometimes artificially insert heavy atoms such as selenium or platinum into the protein for this purpose. But sulfur atoms, which appear naturally throughout protein molecules, can also produce such signals, albeit weaker. Even though these anomalous signals are weak, a big crystal usually has enough copies of the protein with enough sulfur atoms to make them measurable. That gives scientists the phase information needed to pinpoint the location of the sulfur atoms and translate the diffraction patterns into a full 3-D structure.

“Once you know the sulfur positions, you can calculate the phases for the other protein atoms because the relationship between the sulfur and the other atoms is fixed,” said Liu.

But tiny crystals, by definition, don’t have that many copies of the protein of interest. So instead of looking for diffraction and phase information from repeat copies of a protein in a single large crystal, the Brookhaven/Columbia team developed a way to take measurements from many tiny crystals, and then assemble the collective data.

Tiny crystals, big results

To handle the tiny crystals, the team developed sample grids patterned with micro-sized wells. After pouring solvent containing the microcrystals over these well-mount grids, the scientists removed the solvent and froze the crystals that were trapped on the grids.

“We still have a challenge, though, because we can’t see where the tiny crystals are on our grid,” said Liu. “To find out, we used microdiffraction at NSLS-II’s Frontier Microfocusing Macromolecular Crystallography (FMX) beamline to survey the whole grid. Scanning line by line, we can find where those crystals are hidden.”

As Martin Fuchs, the lead beamline scientist at FMX, explained, “The FMX beamline can focus the full intensity of the x-ray beam down to a size of one micron, or millionth of a meter. We can finely control the beam size to match it to the size of the crystals — five microns in the case of the current experiment. These capabilities are crucial to obtain the best signal,” he said.

Wuxian Shi, another FMX beamline scientist, noted that “the data collected in the grid survey contains information about the crystals’ location. In addition, we can also see how well each crystal diffracts, which allows us to pick only the best crystals for data collection.”

The scientists were then able to maneuver the sample holder to place each mapped out microcrystal of interest back in the center of the precision x-ray beam for data collection.

They used the lowest energy available at the beamline — tuned to approach as closely as possible sulfur atoms’ absorption energy — and collected anomalous scattering data.

“Most crystallographic beamlines could not reach the sulfur absorption edge for optimized anomalous signals,” said co-author Wayne Hendrickson of Columbia University. “Fortunately, NSLS-II is a world-leading synchrotron light source providing bright x-rays covering a broad spectrum of x-ray energy. And even though our energy level was slightly above the ideal absorption energy for sulfur, it generated the anomalous signals we needed.”

But the scientists still had some work to do to extract those important signals and assemble the data from many tiny crystals.

“We are actually getting thousands of pieces of data,” said Liu. “We used about 1400 microcrystals, each with its own data set. We have to put all the data from those microcrystals together.”

They also had to weed out data from crystals that were damaged by the intense x-rays or had slight variations in atomic arrangements.

“A single microcrystal does not diffract x-rays sufficiently for structure solution prior to being damaged by the x-rays,” said Sean McSweeney, deputy photon division director and program manager of the Structural Biology Program at NSLS-II. “This is particularly true with crystals of only a few microns, the size of about a bacterial cell. We needed a way to account for that damage and crystal structure variability so it wouldn’t skew our results.”

They accomplished these goals with a sophisticated multi-step workflow process that sifted through the data, discarded outliers that might have been caused by radiation damage or incompatible crystals, and ultimately extracted the anomalous scattering signals.

“This is a critical step,” said Liu. “We developed a computing procedure to assure that only compatible data were merged in a way to align the individual microcrystals from diffraction patterns. That gave us the required signal-to-noise ratios for structure determination.”

Applying the technique

This technique can be used to determine the structure of any protein that has proven hard to crystallize to a large size. These include cell-surface receptors that allow cells of advanced lifeforms such as animals and plants to sense and respond to the environment around them by releasing hormones, transmitting nerve signals, or secreting compounds associated with cell growth and immunity.

“To adapt to the environment through evolution, these proteins are malleable and have lots of non-uniform modifications,” said Liu. “It’s hard to get a lot of repeat copies in a crystal because they don’t pack well.”

In humans, receptors are common targets for drugs, so having knowledge of their varied structures could help guide the development of new, more targeted pharmaceuticals.

But the technique is not restricted to just small crystals.

“The method we developed can handle small protein crystals, but it can also be used for any size protein crystals, any time you need to combine data from more than one sample,” Liu said.

Share Button

Health24.com | ‘Ringing in the ears’ may drive some to the brink of suicide

Imagine a ringing in your ears so intense and unrelenting that you become desperate enough to try to kill yourself.

That is a reality for some – women in particular – who suffer from severe tinnitus, new research shows.

Sex-specific psychological impact

The survey of 72 000 Swedish adults found that 9% of women who suffered from severe tinnitus had attempted suicide, as had 5.5% of men.

After analysing the data, European researchers found that the association between ringing ears and risk for attempted suicide was only significant for women.

“It is important to say that an increased risk of suicide attempts does not mean an increased risk in suicide events,” said lead researcher Christopher Cederroth, from the laboratory of experimental audiology at the Karolinska Institute in Stockholm. Also, only an association and not a cause-and-effect link was observed.

Cederroth added that he isn’t aware of any completed suicides related to tinnitus.

“Our results reflect more the sex-specific psychological impact of tinnitus rather than a risk of committing suicide,” he said.

On the plus side, Cederroth said that the risk for suicide isn’t significant for people who have had their tinnitus treated.

Help is available

“Medical attention by a specialist may help decrease tinnitus-related distress,” he said. “Even though there are currently no treatments to get rid of tinnitus, seeing a specialist may help decrease the distress and diminish the risk of suicide attempts.”

Dr Darius Kohan, director of otology/neurotology at Lenox Hill Hospital and the Manhattan Eye Ear and Throat Hospital in New York City, reviewed the study. He said that although the cause of most tinnitus isn’t known, ways to help people cope with the condition are available.

“Tinnitus can be very severe and debilitating,” Kohan said, noting that it’s a very common condition, affecting about 20% of the population. He isn’t sure why the association between tinnitus and suicide risk appears more serious in women than men. Perhaps it’s just the way the study was done, he said.

“It’s old age and degeneration of the blood supply to the inner ear, plus hearing loss as the nerve cells die off,” said Kohan. In addition, stress, caffeine and aspirin can cause tinnitus, he said.

Treatment usually involves helping people cope with the condition, Kohan said. Treatments can include cutting out caffeine and aspirin and also taking supplements such as Ginkgo biloba or B vitamins.

Most insurance doesn’t cover treatment

In addition, patients can use various devices to provide a background sound to mask the ringing in their ears. These can include white noise generators, an air conditioner, or even the TV, Kohan said. This can be especially effective at night when tinnitus can be at its worst.

Other treatments that may work are acupuncture and cognitive behavioural therapy, Kohan said. Patients can be taught to ignore the sound. Some patients may also need antidepressants or anti-anxiety medications, he added.

Richard Tyler, an audiologist and professor in the department of communication sciences and disorders at the University of Iowa, said that most insurance doesn’t cover treatment for tinnitus.

“It certainly is true that many tinnitus sufferers have severe problems with thoughts and emotions, hearing, sleep and concentration,” Tyler said. “Unfortunately, there is no reimbursement to the hearing health care field for counselling and sound therapy. This is a major obstacle.”

The report was published online in the journal JAMA Otolaryngology-Head & Neck Surgery.

Image credit: iStock

Share Button

These Are the Most Googled Diseases in Every State

It’s no surprise that Google is everyone’s first stop when it comes to health. When an unusual symptom strikes or you have a burning health question, it's just way easier to look it up online than swing by a doctor's office or the local ER.

But interestingly, a lot of us are Googling the same exact health topics, particularly the ones our neighbors are looking up, too. Life insurance company TermLife2Go compiled a list of the most-Googled diseases across the United States over the past year. One result that stands out? Just about everyone in the U.S. wants to know about HPV. 

Yep, human papillomavirus (HPV) is the most-searched disease term across the United States, according to the survey, with 16 states listing it as their number one Googled disease. Considering that 79 million Americans have one or more types of this virus (which may lead to subsequent conditions such as warts and cervical cancer, depending on the type of HPV you have), it’s no surprise it's such a popular search term. 

RELATED: The Healthiest States in the U.S.

Celiac, diabetes, and asthma also made it into some of the top Google searches, along with AIDS and liver disease. Illinois was the only state to have relapsing polychondritis as their most searched-for disease; it's a rare autoimmune disorder that causes recurrent inflammation of joints and tissue. 

It's important to note that no definitive correlation exists between a state and its most Googled disease. But some interesting connections might be made from this data. West Virginia and Iowa, which have the first and fourth highest obesity rates in the nation, respectively, both searched for conditions that can be caused by obesity (diabetes in Iowa, and stroke in West Virginia).

Kentucky and Tennessee both had asthma as one of their most Googled search terms, and ironically, these neighboring states rank third and fifth for the highest percentage of adult smokers, respectively. (Exposure to cigarette smoke can cause of asthma.) Additionally, Delaware's most Googled disease was liver disease, and this smallest U.S. state ranks third per capita in the country for highest alcohol consumption—one possible cause of liver disease. 

Take a look at the full list of every state’s most Googled diseases—you might be surprised which conditions your state is most concerned about!

  • Alabama: AIDS
  • Alaska: Asthma, Stroke, Liver disease
  • Arizona: HPV
  • Arkansas: HPV
  • California: HPV
  • Colorado: Asthma
  • Connecticut: Asthma
  • Delaware: Liver disease
  • Florida: Cancer, HPV
  • Georgia: HPV
  • Hawaii: Diabetes
  • Idaho: Celiac
  • Illinois: Relapsing Polychondritis
  • Indiana: Diabetes, HPV
  • Iowa: Diabetes
  • Kansas: Celiac
  • Kentucky: Emphysema, Asthma
  • Louisiana: AIDS
  • Maine: Heart disease, Ebola virus, Lyme disease
  • Maryland: HPV
  • Massachusetts: Alzheimer’s
  • Michigan: HPV
  • Minnesota: Epilepsy
  • Mississippi: AIDS, Multiple sclerosis
  • Missouri: Colitis
  • Montana: Rheumatoid arthritis, Celiac
  • Nebraska: Scleroderma
  • Nevada: HPV
  • New Hampshire: Celiac
  • New Jersey: Colitis
  • New Mexico: Diabetes
  • New York: Cancer, HPV, Colitis, Crohn’s
  • North Carolina: HPV
  • North Dakota: Liver disease
  • Ohio: HPV
  • Oklahoma: Lupus
  • Oregon: AIDS
  • Pennsylvania: HPV
  • Rhode Island: HPV
  • South Carolina: Scleroderma
  • South Dakota: Diabetes
  • Tennessee: Asthma
  • Texas: HPV
  • Utah: Celiac
  • Vermont: Alzheimer’s
  • Virginia: HPV
  • Washington: HPV
  • West Virginia: COPD, Stroke, Kidney disease, Rheumatoid arthritis
  • Wisconsin: Diabetes, Celiac
  • Wyoming: Pulmonary hypertension, Crohn’s

RELATED: 10 Most Depressing States in the U.S.

Share Button

Gay HIV transmission with treatment is ‘zero risk’, study confirms

A European study followed 972 male couples, where one was living with HIV, over an eight-year period.

Share Button

Bell’s palsy: ‘I woke and the night had stolen my smile’

Thousands of people with Bell’s palsy are struggling to get timely treatment, a charity says.

Share Button

Perils of water polo head injuries

Water polo athletes take note: A new study by University of California, Irvine researchers maps out the frequency of head injuries in the sport and reveals which positions are the most vulnerable.

The first-of-its-kind report, which tracked several dozen male collegiate water polo players over three seasons, was published today in PLOS One, a peer-reviewed, open-access scientific journal.

“For years, water polo’s head trauma risks have been downplayed or overshadowed by football-related brain injuries,” said study co-author James Hicks, professor and chair of UCI’s Department of Ecology & Evolutionary Biology. “Our data quantifies the extent of the problem and sets the stage for additional research and possible rule changes or protective gear to improve water polo safety.”

During the study, players wore caps embedded with electronic sensors. Over time, every participant got bopped in the head by balls or rival players, but some fared worse -occasionally far worse — than others.

Offensive players were more likely to get battered than defensive and transition positions (60 percent versus 23 percent and 17 percent, respectively). And swimmers attacking from the left side of the goal suffered more head hits than players on the right, possibly because right-handed athletes commonly throw shots from the left zone, so there’s more activity in that area, researchers theorized.

The most unsafe position, according to the study, was offensive center. On average, those players endured nearly seven blows to the skull per game, which amounted to 37 percent of all head impacts recorded by UCI scientists. In contrast, the second-most vulnerable position, defensive center, averaged two head strikes a game, the study found.

Overall, researchers counted an average of 18 head hits per game. Although no concussions were diagnosed, the force of the blows was “similar to those observed in collegiate soccer, another sport that is commonly studied for the risks associated with repeated head impact exposure,” Hicks said.

Next up, UCI researchers are preparing a manuscript that details how water polo head shots affect brain function.

Hicks got interested in the subject while watching his three sons play the sport. “People who’ve never seen a game may not realize how physical it is,” he said. “Head-butts and elbows. Balls flying up to 50 mph. I’ve witnessed players get dragged out of the pool in a daze after a blow to the head, and I’ve sat in an emergency room while my kid received stitches from being struck in the face. I began to wonder what the concussion rate was.”

After discovering a dearth of studies, he launched his own. In the first, published three years ago in Frontiers in Neurology, Hicks and Dr. Steven Small, UCI professor of neurology, surveyed 1,500 USA Water Polo members and discovered that 36 percent recalled suffering at least one concussion during their playing career.

Story Source:

Materials provided by University of California – Irvine. Note: Content may be edited for style and length.

Share Button

These trippy images were designed by AI to super-stimulate monkey neurons

To find out which sights specific neurons in monkeys “like” best, researchers designed an algorithm, called XDREAM, that generated images that made neurons fire more than any natural images the researchers tested. As the images evolved, they started to look like distorted versions of real-world stimuli. The work appears May 2 in the journal Cell.

“When given this tool, cells began to increase their firing rate beyond levels we have seen before, even with normal images pre-selected to elicit the highest firing rates,” explains co-first author Carlos Ponce, then a post-doctoral fellow in the laboratory of senior author Margaret Livingstone at Harvard Medical School and now a faculty member at Washington University in St. Louis.

“What started to emerge during each experiment were pictures that were reminiscent of shapes in the world but were not actual objects in the world,” he says. “We were seeing something that was more like the language cells use with each other.”

Researchers have known that neurons in the visual cortex of primate brains respond to complex images, like faces, and that most neurons are quite selective in their image preference. Earlier studies on neuronal preference used many natural images to see which images caused neurons to fire most. However, this approach is limited by the fact that one cannot present all possible images to understand what exactly will best stimulate the cell.

The XDREAM algorithm uses the firing rate of a neuron to guide the evolution of a novel, synthetic image. It goes through a series of images over the course of minutes, mutates them, combines them, and then shows a new series of images. At first, the images looked like noise, but gradually they changed into shapes that resembled faces or something recognizable in the animal’s environment, like the food hopper in the animals’ room or familiar people wearing surgical scrubs. The algorithm was developed by Will Xiao in the laboratory of Gabriel Kreiman at Children’s Hospital and tested on real neurons at Harvard Medical School.

“The big advantage of this approach is that it allows the neuron to build its own preferred images from scratch, using a tool that is not limited by much, that can create anything in the world or even things that don’t exist in the world,” says Ponce.

“In this way we have evolved a super-stimulus that drives the cell better than any natural stimulus we could guess at,” says Livingstone. “This approach allows you to use artificial intelligence to figure out what triggers neurons best. It’s a totally unbiased way of asking the cell what it really wants, what would make it fire the most.”

From this study, the researchers believe they are seeing that the brain learns to abstract statistically relevant features of its world. “We are seeing that the brain is analyzing the visual scene, and driven by experience, extracting information that is important to the individual over time,” says Ponce. “The brain is adapting to its environment and encoding ecologically significant information in unpredictable ways.”

The team believes this technology can be applied to any neuron in the brain that responds to sensory information, such as auditory neurons, hippocampal neurons, and prefrontal cortex neurons where memories can be accessed. “This is important because as artificial intelligence researchers develop models that work as well as the brain does — or even better — we will still need to understand which networks are more likely to behave safely and further human goals,” Ponce says. “More efficient AI can be grounded by knowledge of how the brain works.”

This work was supported by grants from the National Institutes of Health and the National Science Foundation.

Story Source:

Materials provided by Cell Press. Note: Content may be edited for style and length.

Share Button

New clues to coastal erosion

New research has uncovered a missing nutrient source in coastal oceans, which could promote better water quality and sand management on popular beaches.

While the release of nutrients buried in the seabed ‘feeds’ coastal marine ecosystems, the latest research at Flinders University has found a new physical mechanism which erodes seabed sediment at depths up to 20 metres, well outside (between 10km and 20km) from the surf zone closer to shore.

This powerful natural process that is energetic enough to erode seabed sediment at up to 20 m, also adds to the nutrients stirred and moved by breaking surface waves nearer the beach, according to the new hydrodynamic modelling.

“This new knowledge has significant implications for coastal sediment management practices such as dredging,” says Flinders University oceanographer Associate Professor Jochen Kaempf.

The study reveals that major sediment erosion follows from coast-parallel winds in an oceanic situation known as downwelling.

“Such winds trigger a swift coastal current — left-bounded by the coast in the Southern Hemisphere — that is accompanied by a vigorous stirring zone in nearshore waters,” Associate Professor Kaempf says.

While this finding explains the high proportion of recycled nutrients in coastal ecosystems, it incidentally also points to a new mechanism of wind-driven sediment drift in coastal oceans that complements the well-known littoral drift in the surf zone.

“Along the Adelaide metropolitan coastline, for example, the wind-driven sediment drift tends to be predominantly southward and opposite to the northward sediment drift in the surf zone,” explains Dr Kaempf.

“On the other hand, high turbidity levels following a seabed erosion event negatively impact the health of seagrass beds, and the sudden nutrient release can also trigger potentially harmful toxic algae blooms,” says Dr Jochen Kaempf, who also is South Australian branch president of the Australian Meteorological and Oceanographic Society.

Dr Kaempf’s latest paper calls for more field research and the development of reliable ocean forecasting models to study and predict the occurrence of such erosion events.

Story Source:

Materials provided by Flinders University. Note: Content may be edited for style and length.

Share Button

Health24.com | Finasteride can lower prostate cancer risk – safely

Finasteride, best known as the enlarged-prostate medicine Proscar, is a safe, effective way to reduce the risk of prostate cancer, according to long-term findings from the Prostate Cancer Prevention Trial (PCPT).

The trial was funded by the US National Cancer Institute and enrolled nearly 19 000 men between 1993 and 1997.

No significant increased risk of death

Initially it found that finasteride – a hormone-blocking drug – cut the risk of prostate cancer by 25%. Those results were published in 2003.

The newly released long-term data show that the reduction of prostate cancer risk has continued and that fewer than 100 men in the trial died from prostate cancer in more than two decades of follow-up, according to a research team led by Dr Ian Thompson.

The updated results also showed no statistically significant increased risk of death from prostate cancer among men taking finasteride. This removes concerns over early findings of a possible risk of more aggressive cancers among patients who take the drug.

“Finasteride is safe, inexpensive and effective as a preventive strategy for prostate cancer,” said Thompson, who is principal investigator of the PCPT for the SWOG Cancer Research Network.

The SWOG Cancer Research Network is an international cancer clinical trials group.

“Doctors should share these results with men who get regular prostate-specific antigen [PSA] tests that screen for the presence of prostate cancer,” Thompson said in a SWOG news release. “The drug will have its greatest effect in this group of men.”

A big impact on public health

Thompson is also emeritus professor at the University of Texas Health Science Center. He and his team published their findings in the New England Journal of Medicine.

A cheap, reliable prostate cancer prevention drug will have a big impact on public health, Thompson and his colleagues said.

They noted that prostate cancer rates are on the rise and that nearly 165 000 American men were diagnosed with the cancer in 2018, according to the American Cancer Society.

Many cases of prostate cancer are slow-growing and not life-threatening, but are still often treated with surgery and radiation, sometimes resulting in complications such as impotence and incontinence.

“There are significant negative consequences to patients’ health and quality of life that can result from prostate cancer treatment, as well as to their finances and their peace of mind,” Thompson said.

“If we can save people from surgeries and scores of examinations and tests, and spare them from living for years with fear, we should. The best-case scenario for patients is prevention, and this trial has found an inexpensive medication that gets us there,” he concluded.

One prostate specialist unconnected to the research said the new findings come after “many years of debate” on finasteride’s role in cancer prevention.

Warning ‘effectively nullified’ benefits

Based on early findings from the PCPT, the US Food and Drug Administration “issued a warning that chronic use of the medication may increase the risk of high-grade or aggressive prostate cancer in a small percentage of men,” said Dr Manish Vira. He helps direct urologic research at Northwell Health’s Arthur Smith Institute for Urology in Lake Success, New York.

Unfortunately, that warning “effectively nullified the benefits of the medication in the eyes of many patients and their physicians,” Vira said.

These later, fuller results should turn that around, he noted.

“Physicians and patients need to be aware of these results, and at least consider again using these medications in the prevention of prostate cancer,” Vira said.

“This may be especially true among men at high risk, such as African-American men and men with a strong family history of prostate cancer,” he said.

Image credit: iStock

Share Button